Skip to main content

6Node page

what any key link opens

psx:substance/diphenhydramine/claim/3f6574ef-1a3d-4538-aced-4dc93100f46a

claim2026-04-24workinginconclusive

derived from · upstream

feeds · downstream

Closure of psx:substance/diphenhydramine/claim/3f6574ef-1a3d-4538-aced-4dc93100f46a: 57 upstream, 142 downstream.

psx:substance/diphenhydramine/claim/3f6574ef-1a3d-4538-aced-4dc93100f46a
├─ used  src/doi:10.1111/1556-4029.70239  Death due to diphenhydramine toxicity: A 9-year review from the Cook County Medical Examiner's Office and a review of the literature.
  ├─ informed_by  claim/c00d73e0-31f8-4fd7-9570-d9a34cff36f6  Claim in summary — inconclusive  working
  ├─ informed_by  claim/6e5d6097-1357-4e17-92c4-2a73f6163ecb  Claim in summary — inconclusive  working
  ├─ informed_by  claim/3651e6f6-2b27-43db-b18e-43d2789dcafc  Claim in summary — inconclusive  working
  ├─ informed_by  claim/0899e4c7-e74a-4763-91ac-59874fa846d3  Claim in summary — inconclusive  working
  ├─ informed_by  claim/231b0b84-ffa1-47c3-baa6-c3bb7b5a5df5  Claim in summary — inconclusive  working
  ├─ informed_by  claim/d499982c-38a0-4273-ab36-cdeb335c5c21  Claim in summary — inconclusive  working
  ├─ informed_by  claim/f626b320-62dc-40ff-aed6-edbbe8f8d29f  Claim in summary — inconclusive  working
  ├─ informed_by  claim/8582bb24-971a-4c55-8025-5166c29104c0  Claim in summary — inconclusive  working
  ├─ informed_by  claim/1e3011c9-68fb-4580-a219-7daffa9d3e9a  Claim in summary — inconclusive  working
  ├─ informed_by  claim/31ea5422-1b9c-47e8-92a5-094042e8764d  Claim in summary — inconclusive  working
  ├─ informed_by  claim/62a66ef6-0a6a-4edb-bffd-ea8712d29cdd  Claim in summary — inconclusive  working
  ├─ informed_by  claim/1faab378-3572-4a20-8961-bc28a94789de  Claim in summary — inconclusive  working
  ├─ informed_by  claim/ecd90a30-5551-4a5a-9bc5-92a35c33310d  Claim in summary — inconclusive  working
  ├─ informed_by  claim/5e6f21e8-c1e8-4748-a49f-5f4e83b311f6  Claim in summary — inconclusive  working
    ├─ used  src/url:736c295bfa3d18f9  Benadryl: Allergy Relief for Millions - American Chemical Society
    ├─ used  src/url:b8e942ad30117904  Australia TGA Scheduling - Diphenhydramine Schedule 4 (July 1, 2026)
    ├─ used  src/pmid:1685127  Trifluoperazine inhibits phosphoinositide hydrolysis as a histamine H1-receptor antagonist.
    ├─ used  src/pmid:16453179  Antimuscarinic actions of antihistamines on the heart.
    ├─ used  src/doi:10.1016/j.ajem.2026.01.040  Lidocaine for diphenhydramine-induced ventricular tachycardia: A case report.
    ├─ used  src/doi:10.1016/j.neuropharm.2015.08.021  Open channel block of NMDA receptors by diphenhydramine.
    ├─ used  src/pmid:12678691  Classic histamine H1 receptor antagonists: a critical review of their metabolic and pharmacokinetic fate from a bird's eye view.
    ├─ used  src/url:de86627bfcc84cd5  Diphenhydramine Toxicity - StatPearls (NBK557578)
    ├─ used  src/doi:10.1055/s-0032-1332949  [Diphenhydramine addiction and detoxification. A systematic review and case report].
    ├─ used  src/doi:10.1186/s13195-025-01883-8  Anticholinergic burden and incident dementia: a Swedish nationwide case-control study.
    ├─ used  src/doi:10.3389/fphar.2018.00913  A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research.
    ├─ used  src/url:c28d60b998176c0e  Diphenhydramine - Wikipedia
    ├─ used  src/url:b060ec4995f7a05b  Diphenhydramine legal status by jurisdiction (Erowid/Wikipedia/ACS sources combined)
    ├─ used  src/doi:10.1111/1556-4029.15149  A TikTok 'Benadryl Challenge' death - A case report and review of the literature.
    ├─ used  src/doi:10.1080/15563650.2019.1609683  Adverse events associated with diphenhydramine in children, 2008-2015.
    ├─ used  src/doi:10.1124/pr.114.010249  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.
    ├─ used  src/pmid:3100  Diphenhydramine - PubChem Compound
    ├─ used  src/url:5897be19afc8eb58  Diphenhydramine - StatPearls (NBK526010)
    ├─ used  src/pmid:2419744  H1-histamine receptors on human astrocytoma cells.
    ├─ used  src/doi:10.7759/cureus.70719  Diphenhydramine Overdose: A Case Report and Topic Review of Prehospital Diagnosis and Treatment.
    ├─ used  src/doi:10.1007/s13181-015-0483-y  A Literature Review of the Use of Sodium Bicarbonate for the Treatment of QRS Widening.
    ├─ used  src/pmid:12851661  Pharmacokinetics of diphenhydramine in healthy volunteers with a dimenhydrinate 25 mg chewing gum formulation.
    ├─ used  src/pmid:3718600  [Pharmacokinetics and bioavailability of diphenhydramine in man].
    ├─ used  src/pmid:2866055  Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines).
    ├─ used  src/pmid:2328304  Diphenhydramine kinetics following intravenous, oral, and sublingual dimenhydrinate administration.
    ├─ used  src/doi:10.5664/jcsm.6470  Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.
    ├─ used  src/pmid:16401664  Sedation and memory: studies with a histamine H-1 receptor antagonist.
    ├─ used  src/pmid:12826988  Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly subjects.
    ├─ used  src/pmid:9443520  Lack of sedative and cognitive effects of diphenhydramine and cyclobenzaprine in elderly volunteers.
    ├─ used  src/pmid:33053  Effects of terfenadine and diphenhydramine alone or in combination with diazepam or alcohol on psychomotor performance and subjective feelings.
    ├─ used  src/doi:10.1016/j.cct.2022.106976  Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.
    ├─ used  src/pmid:7497894  [An anticholinergic syndrome with hallucinatory psychosis after diphenhydramine poisoning].
    ├─ used  src/url:bc4c41cd5fbd55d0  LD50 data for diphenhydramine hydrochloride (MSDS/safety data)
    ├─ used  src/doi:10.1007/s12024-012-9383-5  Toxicological identification of diphenhydramine (DPH) in suicide.
    ├─ used  src/pmid:9662109  Diphenhydramine toxicity: comparisons of postmortem findings in diphenhydramine-, cocaine-, and heroin-related deaths.
    ├─ used  src/doi:10.12659/AJCR.912523
    ├─ used  src/doi:10.1007/s13181-018-0672-6  Extracorporeal Cardiopulmonary Resuscitation After Diphenhydramine Ingestion.
    ├─ used  src/doi:10.1177/1060028019846654  A Comparison of Resource Utilization in the Management of Anticholinergic Delirium Between Physostigmine and Nonantidote Therapy.
    ├─ used  src/doi:10.1007/s13181-014-0452-x  The Use of Physostigmine by Toxicologists in Anticholinergic Toxicity.
    ├─ used  src/doi:10.1001/jama.2025.23247  Restless Legs Syndrome: A Review.
    ├─ derived_from  gen/ab49b39b-a470-4602-ac92-a0c81fbb93e4  Generation — pipeline-v5
    └─ generated_by  pub/fa9daa3e-7f00-4c3f-9988-ab930a59e490  Publication — backfill
├─ informed_by  section/summary.full@1
  ├─ used  version/1  Revision 1
  ├─ used  claim/f4bbcb02-479a-4087-a9de-cfa9518bb140  Claim in history — inconclusive  working
  ├─ used  claim/4a6bf0c9-0883-4060-b208-660536eeba7e  Claim in safety — inconclusive  working
  ├─ used  claim/6e756118-0a27-40f8-affc-504929ef4207  Claim in safety — inconclusive  working
  ├─ used  claim/fa0945a5-1ecc-4c59-8809-de74d978ac76  Claim in summary — inconclusive  working
  ├─ used  claim/346e982c-463c-4bc0-a270-6549a81869dc  Claim in history — inconclusive  working
  ├─ used  claim/a741da06-7735-431c-b055-0de4dfa2c947  Claim in safety — inconclusive  working
  ├─ used  claim/5060fd40-109b-480a-bdcd-35cf90764982  Claim in safety — inconclusive  working
    ├─ derived_from  issue/notice@034a58fba8b8  Issued notice
    ├─ derived_from  issue/info_card@348705653ea5  Issued info_card
    ├─ derived_from  issue/emergency@e2acd002694f  Issued emergency
    ├─ derived_from  issue/info_card@eb1efe8b4354  Issued info_card
    ├─ derived_from  issue/emergency@202c57e4fe57  Issued emergency
    ├─ informed_by  section/history.full@1
    ├─ informed_by  section/safety.full@1
      ├─ used  claim/3a47dfb5-0e70-4fe6-a30c-05ed915c4397  Claim in pharmacology — inconclusive  working
      ├─ used  claim/ea63236c-70c2-4e45-8d9d-dba58bc1f2cf  Claim in pharmacology — inconclusive  working
      ├─ used  claim/831ce7c8-325c-4392-b0ec-e94d3c33e473  Claim in pharmacology — inconclusive  working
      ├─ used  claim/25ebd381-44b8-4361-8a86-9ad5c0fd3762  Claim in comparative-pharmacology — inconclusive  working
      ├─ used  claim/d00cc8fd-0b6a-42c9-8f48-0e80c817d991  Claim in pharmacology — inconclusive  working
      ├─ used  claim/4dc55c8e-c28e-41ca-b7ff-1d6672b730c9  Claim in comparative-pharmacology — inconclusive  working
      ├─ used  claim/30ccd46c-3460-4d53-a2ce-da29c2ff72b0  Claim in pharmacology — inconclusive  working
      ├─ used  claim/601f75c3-c54e-4309-b630-d669940e7a53  Claim in pharmacology — inconclusive  working
      ├─ used  claim/73be9ec7-0449-476f-85ba-bd0dc9267db4  Claim in receptor-pharmacology — inconclusive  working
      ├─ used  claim/119f701a-4cc5-4de3-a72e-91ef5dd48be5  Claim in safety — inconclusive  working
      ├─ used  claim/563a0b15-056f-4d14-9b04-e89db769ca54  Claim in safety — inconclusive  working
      ├─ used  claim/629887d4-f6a8-4181-bb26-848173b33503  Claim in comparative-pharmacology — inconclusive  working
      ├─ used  claim/ff22aa0d-83ae-4d3f-ab94-1cdb07c5c4e6  Claim in pharmacology — inconclusive  working
      ├─ used  claim/91873711-eddd-4a94-9dd0-30b15c6372a8  Claim in pharmacology — inconclusive  working
      ├─ used  claim/f94ae87a-cf89-44c9-add3-aa0ff4a48170  Claim in receptor-pharmacology — inconclusive  working
      ├─ used  claim/bfd861bc-32e6-4dce-8215-7966fbcef1c8  Claim in safety — inconclusive  working
      ├─ used  claim/758584d0-4950-4936-bad2-225986894cbc  Claim in safety — inconclusive  working
      ├─ used  claim/4bcff25d-c81a-437e-a396-417ce0d48ef1  Claim in comparative-pharmacology — inconclusive  working
      ├─ used  claim/ac4be8a5-820b-47ef-8607-c9ac248e5e56  Claim in pharmacology — inconclusive  working
      ├─ used  claim/d5169e65-1537-409b-82cc-542ed705ffea  Claim in neuroscience — inconclusive  working
      ├─ used  claim/9ea0dd8e-09c7-43b9-9ef7-6a8afe39bce2  Claim in neuroscience — inconclusive  working
      ├─ used  claim/82813d9f-5be2-4723-a84d-d9d5b0cc0efa  Claim in pharmacology — inconclusive  working
      ├─ used  claim/d911a813-712f-4b45-855e-ee4e703fd21d  Claim in neuroscience — inconclusive  working
      ├─ used  claim/e556caf9-6549-4db7-8fe5-de10c8f25696  Claim in neuroscience — inconclusive  working
      ├─ used  claim/187b350e-6279-42ec-ad5a-2d093b4bb3cb  Claim in safety — inconclusive  working
      ├─ used  claim/56a72208-6d95-4684-8b85-a755a08420ac  Claim in pharmacology — inconclusive  working
      ├─ used  claim/04333e49-1cd0-4232-a0c2-a5164fd341da  Claim in pharmacology — inconclusive  working
      ├─ used  claim/7cfc2e59-14f1-4c58-b433-8f7795828f1c  Claim in pharmacology — inconclusive  working
      ├─ used  claim/6bf987fa-7e83-4a95-9beb-41dc402d621d  Claim in pharmacokinetic-detail — inconclusive  working
      ├─ used  claim/bfe03d53-983e-4500-a71f-90a62a22c1c3  Claim in pharmacokinetic-detail — inconclusive  working
      ├─ used  claim/3a8fa460-b7bd-4d67-9812-7f1b35ffeb7b  Claim in pharmacokinetic-detail — inconclusive  working
      ├─ used  claim/3fda0657-9326-4eb0-9ce1-29dc3d64adbf  Claim in pharmacology — inconclusive  working
      ├─ used  claim/d04f6f99-ce7b-4c12-8be9-f7eceaf1d73c  Claim in pharmacology — inconclusive  working
      ├─ used  claim/85afec6c-8a78-4d6e-8c7d-99f0b19f21e1  Claim in pharmacology — inconclusive  working
      ├─ used  claim/6d81e034-84ca-48dd-9912-c4cc21784d7f  Claim in safety — inconclusive  working
      ├─ used  claim/eaa5fa35-f209-4cda-b000-ce74588e8e6d  Claim in pharmacokinetic-detail — inconclusive  working
      ├─ used  claim/08d90776-a60b-4c92-b38e-eac311e021b6  Claim in pharmacokinetic-detail — inconclusive  working
      ├─ used  claim/3f8d31da-b698-4efe-a9a9-695ac9584ba8  Claim in pharmacokinetic-detail — inconclusive  working
      ├─ used  claim/717e0fd6-6dda-41fc-9c2e-35e06530ed04  Claim in safety — inconclusive  working
      ├─ used  claim/3a40b89c-0f1c-47bc-9f50-98cefee8f645  Claim in safety — inconclusive  working
      ├─ used  claim/964b7523-b5f2-4d81-bf16-266f53385cf4  Claim in safety — inconclusive  working
      ├─ used  claim/4ace488d-5c3a-4e84-af56-9300d105df44  Claim in safety — inconclusive  working
      ├─ used  claim/5628a006-9976-4fb9-85aa-eef65660fb61  Claim in safety — inconclusive  working
      ├─ used  claim/6e8653b6-75a6-4d32-afb0-3cde15fdaf12  Claim in neuroscience — inconclusive  working
      ├─ used  claim/e7a6818d-d488-4c5b-8607-6dbefff0cc4b  Claim in neuroscience — inconclusive  working
      ├─ used  claim/5f4a5ab4-e602-4f8f-8f63-0cc057aa737d  Claim in safety — inconclusive  working
      ├─ used  claim/1e4f3325-bab7-4b28-afff-2591f72a89e3  Claim in neuroscience — inconclusive  working
      ├─ used  claim/4fd1f0d7-8afa-4d21-92a9-2b450b1dbcc5  Claim in neuroscience — inconclusive  working
      ├─ used  claim/1655c547-b4af-40f7-8c92-88a1a90bc0be  Claim in history — inconclusive  working
      ├─ used  claim/f337b301-be0f-4c62-97b5-737da630459a  Claim in history — inconclusive  working
      ├─ used  claim/246ac6dd-ea2b-4b08-8617-cc88fdbf158f  Claim in chemistry — inconclusive  working
      ├─ used  claim/57db9615-4dd3-4d4e-abe4-c8ac8e13791b  Claim in chemistry — inconclusive  working
      ├─ used  claim/74a92aa2-042d-40c1-a8f4-869ea098c18e  Claim in history — inconclusive  working
      ├─ used  claim/7f64b690-16dd-4c53-a731-2d19d56f202e  Claim in history — inconclusive  working
      ├─ used  claim/0153cd89-67e0-4525-ab26-9cc42f440f77  Claim in chemistry — inconclusive  working
      ├─ used  claim/2a877bd5-237f-4d11-b140-96a8b0a7862d  Claim in chemistry — inconclusive  working
      ├─ used  claim/1aa00df2-fb59-41a6-8afe-02c9305d1c8a  Claim in history — inconclusive  working
      ├─ used  claim/e58d63d3-2bea-4a2b-b5c2-8d6a50d50758  Claim in safety — inconclusive  working
      ├─ used  claim/0fbd25ab-cd18-4197-85cd-99b2ded79b8c  Claim in history — inconclusive  working
      ├─ used  claim/e5837324-87d7-402c-826c-afe41bd54c69  Claim in history — inconclusive  working
      ├─ used  claim/9e32636a-a07e-4053-b392-6f162f712518  Claim in safety — inconclusive  working
      ├─ used  claim/0e3d165e-640b-4c18-9c58-d946bc8bd42b  Claim in history — inconclusive  working
      ├─ used  claim/27d76b21-fc12-4eaa-8e75-879c66eed4ea  Claim in safety — inconclusive  working
      ├─ used  claim/c90f9473-64ea-4959-b5ff-d8da908c8379  Claim in safety — inconclusive  working
      ├─ used  claim/fe45bb48-2972-4853-900f-e9a08b7c44f3  Claim in safety — inconclusive  working
      ├─ used  claim/124031d4-d738-4a3b-b93f-41d56fdd8155  Claim in safety — inconclusive  working
      ├─ used  claim/7a9aee4f-85f6-4889-8543-24d7c4c84f44  Claim in history — inconclusive  working
      ├─ used  claim/4bbcef54-c79a-4284-8582-d268c4369f43  Claim in neuroscience — inconclusive  working
      ├─ used  claim/395b08e3-9d4d-46c3-9ec0-541944666cf5  Claim in safety — inconclusive  working
      ├─ used  claim/4c0f9a86-1051-4ce7-9060-9c4880a965ae  Claim in safety — inconclusive  working
      ├─ used  claim/3d730aab-554c-4b6f-9af4-45e665bb31ec  Claim in safety — inconclusive  working
      ├─ used  claim/03f6c5b1-f3ce-429f-b1ff-d4d223b83981  Claim in safety — inconclusive  working
      ├─ used  claim/9dd05b6a-52ea-480e-9762-0d31731adedb  Claim in history — inconclusive  working
      ├─ used  claim/a761433f-6c4d-43ba-8deb-28678e90208f  Claim in neuroscience — inconclusive  working
      ├─ used  claim/778d3817-b22a-45bc-93a3-b4e985dcff33  Claim in pharmacology — inconclusive  working
      ├─ used  claim/36484c8d-5a5b-4f9e-9d05-e3e0c98d58b4  Claim in pharmacology — inconclusive  working
      ├─ used  claim/a326b0bf-a202-4709-9587-2e1efc042b7f  Claim in pharmacology — inconclusive  working
      ├─ used  claim/76fa6407-802b-4121-94c3-d29237a993fe  Claim in chemistry — inconclusive  working
      ├─ used  claim/b5aa4876-34ec-4f9d-859a-eae0636cb327  Claim in chemistry — inconclusive  working
      ├─ used  claim/be6e8b53-ad43-44bf-940d-6742f744b0af  Claim in chemistry — inconclusive  working
      ├─ used  claim/275ba7c0-83ff-44fb-ab79-79ead89945f9  Claim in receptor-pharmacology — inconclusive  working
      ├─ used  claim/317ab4af-b206-44f0-86c3-ae005a2506bb  Claim in comparative-pharmacology — inconclusive  working
      ├─ used  claim/6c5f3aa0-2a18-4541-958c-084d67c1c82f  Claim in comparative-pharmacology — inconclusive  working
      ├─ used  claim/3fc432c7-033c-4ca6-ab56-b3544a062cc8  Claim in comparative-pharmacology — inconclusive  working
      ├─ used  claim/411cb5a8-0331-4986-aa77-7292c32700c0  Claim in neuroscience — inconclusive  working
      ├─ used  claim/7b523d1d-70b4-44a1-9e19-3b92e27785f0  Claim in neuroscience — inconclusive  working
      ├─ used  claim/7a18b08f-e1d1-4693-8be6-6f75ec25f559  Claim in pharmacology — inconclusive  working
      ├─ used  claim/52812322-2424-4e99-b583-a29c3c992efd  Claim in pharmacology — inconclusive  working
      ├─ used  claim/f83c5a38-132a-4777-8c26-ad5b80a699a8  Claim in pharmacology — inconclusive  working
      ├─ used  claim/f16ca376-a24f-420f-b01f-d79e86e54ad6  Claim in chemistry — inconclusive  working
      ├─ used  claim/e7d2eac4-2268-4bd4-86fd-b7d44ddbffe4  Claim in chemistry — inconclusive  working
      ├─ used  claim/24969500-58af-41ec-8895-b3bb0f1833a0  Claim in chemistry — inconclusive  working
      ├─ used  claim/35a6e38c-c028-4899-8cfc-030216de35e2  Claim in receptor-pharmacology — inconclusive  working
      ├─ used  claim/1164b50a-46a2-479d-becf-67ee957ec6be  Claim in comparative-pharmacology — inconclusive  working
      ├─ used  claim/834ddc4c-4463-4afb-ba03-00de562a8ec1  Claim in comparative-pharmacology — inconclusive  working
      ├─ used  claim/50d432a9-5bf0-41ef-8d88-85d295df40dc  Claim in comparative-pharmacology — inconclusive  working
      ├─ used  claim/d96edbb2-8977-46f4-a6fd-0123310ec6a5  Claim in neuroscience — inconclusive  working
      ├─ used  claim/14c9460f-9ed6-4445-8464-fc19ef5383e6  Claim in neuroscience — inconclusive  working
      ├─ used  claim/fda1e772-9dfd-467e-a39c-077fd2dc08f7  Claim in chemistry — inconclusive  working
      ├─ used  claim/ccd42e5a-0c60-4464-9540-ebab2dbeef24  Claim in chemistry — inconclusive  working
      ├─ used  claim/b7ed1114-5063-42b1-bac2-23a01a7c79c3  Claim in chemistry — inconclusive  working
      ├─ used  claim/33bd38d0-778c-4756-808b-0c878c4d390d  Claim in chemistry — inconclusive  working
      ├─ used  claim/d98bedfa-1888-4f74-923b-f0afffa8376b  Claim in pharmacology — inconclusive  working
      ├─ used  claim/09a43a8e-489c-44e0-bde6-1353d35c8a9e  Claim in pharmacology — inconclusive  working
      ├─ used  claim/38e3aae4-5fa2-4413-966c-db71ca54b4a9  Claim in pharmacology — inconclusive  working
      ├─ used  claim/7b73673a-29d6-44b6-b01e-c83b3858080d  Claim in safety — inconclusive  working
      ├─ used  claim/a0f6ce7d-1134-4a08-a724-c05dae2cd208  Claim in pharmacology — inconclusive  working
      ├─ used  claim/db3f73fe-3d40-4b51-95a1-423723f253bb  Claim in safety — inconclusive  working
      ├─ used  claim/b62a5cb9-f893-41fe-af8f-2d5fd11b7919  Claim in pharmacology — inconclusive  working
      ├─ used  claim/67a7cf1d-abc3-43b0-b653-bffc6ee827b4  Claim in comparative-pharmacology — inconclusive  working
      ├─ used  claim/a4e911db-c9ed-4bef-ab87-97e2c6982fbd  Claim in safety — inconclusive  working
      ├─ used  claim/504d1762-0872-4e95-a890-8e7b66900a92  Claim in pharmacology — inconclusive  working
      ├─ used  claim/0d8cbc12-522d-4c39-a2e5-8a22f3d3676c  Claim in comparative-pharmacology — inconclusive  working
      ├─ used  claim/d67f8c58-1691-4fd1-a7d7-5c6607e25c0d  Claim in safety — inconclusive  working
      ├─ used  claim/97342f02-260d-43eb-ae20-97646107fe8c  Claim in pharmacology — inconclusive  working
      ├─ used  claim/a9d43caa-8ac3-40af-a421-27a81f3d89b4  Claim in pharmacology — inconclusive  working
      ├─ used  claim/97c20c1a-ab35-4e52-b8f3-db13b7153f7e  Claim in pharmacology — inconclusive  working
      ├─ used  claim/cda76b2c-1d64-4282-badf-25a4f93ec85e  Claim in pharmacology — inconclusive  working
      ├─ used  claim/eef66082-647c-473a-ae4a-b43d943bf6d8  Claim in pharmacology — inconclusive  working
      ├─ used  claim/e6fed62f-0ee2-47f8-af8e-132d12698c2e  Claim in pharmacology — inconclusive  working
      ├─ used  claim/eb8b27ba-792e-4531-860e-3b62f1f0d09a  Claim in pharmacology — inconclusive  working
      ├─ used  claim/8a84ba9f-9279-46a0-a0a9-23bf24f370a4  Claim in pharmacology — inconclusive  working
      ├─ used  claim/b94f9ff6-d31d-4c43-899d-5a046dea4284  Claim in safety — inconclusive  working
      ├─ used  claim/e53051c5-e13a-4134-b6c8-9b5abb965d2b  Claim in pharmacology — inconclusive  working
      ├─ used  claim/23d9d323-8795-44d4-b025-3d58745782c2  Claim in pharmacology — inconclusive  working
      └─ used  claim/4998dde1-8ff1-400e-a975-52dc8679e5aa  Claim in pharmacology — inconclusive  working
… closure truncated at 200 nodes

indented by distance from this node, not by parentage

1Provenance card

the boundary, as counts

Sources

4119 with DOI

8 strong · 19 moderate · 14 weak

Compilations

12026-04-24T13:01:15.584Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09 · 1 other run

Decisions

35last ruled 2026-06-04

0 awaiting a ruling

Issued documents

52026-10-19T20:31:32.665Z

notice · info card · emergency

Searches

310 with no results

queries and counts on the build

Claims checked

2021 supported

1 supported · 201 not

Correspondence

0received

consent field ships in Phase 4

Edges

525

derivations recorded for this entity

Complete over 41 sources, 1 compilation, and 35 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/diphenhydramine/archive

2Build

one panel per compilation run

generation run 2026-04-24

59 min completedmodel pipeline-v5plan not recordedrun/e7675f9b…

Selection

results seen149
selected by the model62
consumed as sources41

Verification

claims checked202
supported0
partially supported1
not supported0
inconclusive201
  • record
  • seen / partial
  • working

The model's own caveats

  • taper_unassessed
  • withdrawal_documented_but_mild
  • no_guidelines_body_recommendation

Reproduce

inputs
41 source keys (listed under Sources)
plan
not recorded — template version, prompt hash and git SHA are written from 2026-09 onward
model
pipeline-v5
streams
none — agent transcripts are persisted from 2026-09 onward
31 searches — query, source, results, what was kept and why
31 searches for this run
#sourcequeryseenkeptrationale
1PubMeddiphenhydramine overdose toxicity fatal death case report95Critical safety/toxicity data including lethal concentrations
2PubChemdiphenhydramine11Primary compound identity verification
3PubMeddiphenhydramine pharmacology receptor binding histamine muscarinic103Directly relevant binding affinity and receptor pharmacology data
4OpenAlexdiphenhydramine pharmacology antihistamine anticholinergic101IUPHAR histamine receptor review provides authoritative receptor classification context
5PubMeddiphenhydramine pharmacokinetics bioavailability half-life metabolism human76Human PK data directly relevant to dosing and duration sections
6PubMeddiphenhydramine NMDA receptor open channel block11Novel receptor mechanism beyond H1/muscarinic
7WebSearchdiphenhydramine discovery George Rieveschl 1943 synthesis history Parke-Davis FDA approval103Historical discovery narrative not available in PubMed; web sources provide documented institutional history
8PubMeddiphenhydramine psychotropic effects doses subjective effects volunteers55Human controlled studies of DPH subjective and psychomotor effects
9PubMedanticholinergic drugs dementia risk cumulative burden older adults82Chronic risk data from anticholinergic exposure relevant to DPH chronic toxicity
10PubMedSanger antiemetic history nausea vomiting antihistamine discovery dimenhydrinate11Authoritative peer-reviewed history of DPH/dimenhydrinate antiemetic discovery
11ClinicalTrials.govdiphenhydramine sleep aid insomnia treatment placebo controlled101Completed Phase 4 DPH-specific clinical trial for insomnia
12PubMedphysostigmine anticholinergic toxidrome treatment reversal82Physostigmine as antidote for DPH-induced anticholinergic toxidrome
13PubMeddiphenhydramine Benadryl challenge social media TikTok adolescent overdose11Directly relevant to harm reduction and social media harm context
14PubMeddiphenhydramine sodium channel blockade cardiac arrhythmia QRS55Critical safety mechanism data - sodium channel blockade explains cardiac toxicity
15WebSearchdiphenhydramine legal status OTC prescription UK Australia Canada scheduling103Legal status by jurisdiction, particularly the recent Australia scheduling change
16WebSearchdiphenhydramine LD50 rat oral mg/kg lethal dose 50 toxicology102Animal toxicity data for safety section
17PubMeddiphenhydramine metabolism CYP2D6 CYP3A4 enzyme inhibition32CYP enzyme involvement directly relevant to drug interactions section
18NCBI Bookshelfdiphenhydramine toxicity StatPearls11Comprehensive toxicity reference with specific dose thresholds and treatment protocols
19IUPHAR/BPS Guide to Pharmacologydiphenhydramine binding affinity all receptors10Could not extract specific Ki values from static page; noted for further investigation
20PubMeddiphenhydramine anticholinergic delirium hallucinations psychosis32Relevant toxicity and subjective effects data
21NCBI Bookshelfdiphenhydramine pharmacology StatPearls11Comprehensive pharmacological reference with specific PK values
22PubMeddiphenhydramine abuse recreational use misuse substance use disorder21Confirms recreational use patterns documented in toxicology literature
23PubMedantihistamine children death pediatric cough cold safety73Critical safety data for pediatric use; hallucinations at 46.5% highly relevant to effects section
24PubMedantihistamine QT prolongation hERG cardiac first-generation31Confirms hERG blocking mechanism of first-generation antihistamines including DPH
25PubMeddiphenhydramine Benadryl challenge social media TikTok adolescent11Critical harm reduction data and contemporary misuse pattern
26NCBI Bookshelfdiphenhydramine pharmacology mechanism11Authoritative reference with specific PK values
27WebSearchdiphenhydramine Australia Schedule 4 2026 TGA rescheduling102Critical recent legal status change
28PubMeddiphenhydramine H1 receptor binding crystal structure52H1R structural pharmacology context
29PubMedrestless legs syndrome antihistamine worsening11Important contraindication for DPH use as sleep aid
30DOI verification via Crossrefverify DOIs for key citations31DOI verification for key high-impact citations
31PubChem CID 3100diphenhydramine chemical identity SMILES formula11Chemical identity verification for seed data
202 claims by section — every cited sentence, checked against its source
safety58 · 1 ok
  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Physostigmine, an acetylcholinesterase inhibitor, reverses the syndrome and is associated with fewer intubations and ICU admissions compared to non-antidote therapy in a cohort of 141 patients.partially supported

    Retrospective analysis of 815 anticholinergic toxidrome patients; physostigmine associated with lower intubation rate (1.9% vs 8.4%). s13181-014-0452-x

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

pharmacology44 · 0 ok
  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

  • Claim in pharmacology — inconclusiveinconclusiveworking →

neuroscience18 · 0 ok
  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

comparative-pharmacology16 · 0 ok
  • Claim in comparative-pharmacology — inconclusiveinconclusiveworking →

  • Claim in comparative-pharmacology — inconclusiveinconclusiveworking →

  • Claim in comparative-pharmacology — inconclusiveinconclusiveworking →

  • Claim in comparative-pharmacology — inconclusiveinconclusiveworking →

  • Claim in comparative-pharmacology — inconclusiveinconclusiveworking →

  • Claim in comparative-pharmacology — inconclusiveinconclusiveworking →

  • Claim in comparative-pharmacology — inconclusiveinconclusiveworking →

  • Claim in comparative-pharmacology — inconclusiveinconclusiveworking →

  • Claim in comparative-pharmacology — inconclusiveinconclusiveworking →

  • Claim in comparative-pharmacology — inconclusiveinconclusiveworking →

  • Claim in comparative-pharmacology — inconclusiveinconclusiveworking →

  • Claim in comparative-pharmacology — inconclusiveinconclusiveworking →

  • Claim in comparative-pharmacology — inconclusiveinconclusiveworking →

  • Claim in comparative-pharmacology — inconclusiveinconclusiveworking →

  • Claim in comparative-pharmacology — inconclusiveinconclusiveworking →

  • Claim in comparative-pharmacology — inconclusiveinconclusiveworking →

summary16 · 0 ok
  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

chemistry14 · 0 ok
  • Claim in chemistry — inconclusiveinconclusiveworking →

  • Claim in chemistry — inconclusiveinconclusiveworking →

  • Claim in chemistry — inconclusiveinconclusiveworking →

  • Claim in chemistry — inconclusiveinconclusiveworking →

  • Claim in chemistry — inconclusiveinconclusiveworking →

  • Claim in chemistry — inconclusiveinconclusiveworking →

  • Claim in chemistry — inconclusiveinconclusiveworking →

  • Claim in chemistry — inconclusiveinconclusiveworking →

  • Claim in chemistry — inconclusiveinconclusiveworking →

  • Claim in chemistry — inconclusiveinconclusiveworking →

  • Claim in chemistry — inconclusiveinconclusiveworking →

  • Claim in chemistry — inconclusiveinconclusiveworking →

  • Claim in chemistry — inconclusiveinconclusiveworking →

  • Claim in chemistry — inconclusiveinconclusiveworking →

clinical-evidence14 · 0 ok
  • Claim in clinical-evidence — inconclusiveinconclusiveworking →

  • Claim in clinical-evidence — inconclusiveinconclusiveworking →

  • Claim in clinical-evidence — inconclusiveinconclusiveworking →

  • Claim in clinical-evidence — inconclusiveinconclusiveworking →

  • Claim in clinical-evidence — inconclusiveinconclusiveworking →

  • Claim in clinical-evidence — inconclusiveinconclusiveworking →

  • Claim in clinical-evidence — inconclusiveinconclusiveworking →

  • Claim in clinical-evidence — inconclusiveinconclusiveworking →

  • Claim in clinical-evidence — inconclusiveinconclusiveworking →

  • Claim in clinical-evidence — inconclusiveinconclusiveworking →

  • Claim in clinical-evidence — inconclusiveinconclusiveworking →

  • Claim in clinical-evidence — inconclusiveinconclusiveworking →

  • Claim in clinical-evidence — inconclusiveinconclusiveworking →

  • Claim in clinical-evidence — inconclusiveinconclusiveworking →

history12 · 0 ok
  • Claim in history — inconclusiveinconclusiveworking →

  • Claim in history — inconclusiveinconclusiveworking →

  • Claim in history — inconclusiveinconclusiveworking →

  • Claim in history — inconclusiveinconclusiveworking →

  • Claim in history — inconclusiveinconclusiveworking →

  • Claim in history — inconclusiveinconclusiveworking →

  • Claim in history — inconclusiveinconclusiveworking →

  • Claim in history — inconclusiveinconclusiveworking →

  • Claim in history — inconclusiveinconclusiveworking →

  • Claim in history — inconclusiveinconclusiveworking →

  • Claim in history — inconclusiveinconclusiveworking →

  • Claim in history — inconclusiveinconclusiveworking →

pharmacokinetic-detail6 · 0 ok
  • Claim in pharmacokinetic-detail — inconclusiveinconclusiveworking →

  • Claim in pharmacokinetic-detail — inconclusiveinconclusiveworking →

  • Claim in pharmacokinetic-detail — inconclusiveinconclusiveworking →

  • Claim in pharmacokinetic-detail — inconclusiveinconclusiveworking →

  • Claim in pharmacokinetic-detail — inconclusiveinconclusiveworking →

  • Claim in pharmacokinetic-detail — inconclusiveinconclusiveworking →

receptor-pharmacology4 · 0 ok
  • Claim in receptor-pharmacology — inconclusiveinconclusiveworking →

  • Claim in receptor-pharmacology — inconclusiveinconclusiveworking →

  • Claim in receptor-pharmacology — inconclusiveinconclusiveworking →

  • Claim in receptor-pharmacology — inconclusiveinconclusiveworking →

Other runs

  1. brief run2026-09-27completed5 minrun/accbee9e…

3Sources

41 consumed · sorted by year · feeds = sections resting on it

Sources 1 to 30
yearsourcetierstatusfeeds
2026Australia TGA Scheduling - Diphenhydramine Schedule 4 (July 1, 2026)Therapeutic Goods Administration (TGA)url:b8e942ad30117904weakconsumedcited only
2026Death due to diphenhydramine toxicity: A 9-year review from the Cook County Medical Examiner's Office and a review of the literature.Macorano E, Tarozzi I, Gitto L · Journal of Forensic Sciencesdoi:10.1111/1556-4029.70239moderateconsumed3 sections
2026Lidocaine for diphenhydramine-induced ventricular tachycardia: A case report.Carroll S, McGee M, Audette M, Tuttle M, Corcoran J, Stanton M, Feldman R · The American Journal of Emergency Medicinedoi:10.1016/j.ajem.2026.01.040weakconsumed5 sections
2026Restless Legs Syndrome: A Review.Winkelman JW, Wipper B · JAMAdoi:10.1001/jama.2025.23247strongconsumed1 section
2025Anticholinergic burden and incident dementia: a Swedish nationwide case-control study.Zhu N, Eriksdotter M, Liabeuf S, Tan ECK, Johnell K, Garcia-Ptacek S, Xu H · Alzheimer's Research & Therapydoi:10.1186/s13195-025-01883-8moderateconsumed3 sections
2024Benadryl: Allergy Relief for Millions - American Chemical SocietyAmerican Chemical Societyurl:736c295bfa3d18f9weakconsumedcited only
2024Diphenhydramine - PubChem CompoundNational Library of Medicinepmid:3100moderateconsumed1 section
2024Diphenhydramine - WikipediaWikipedia contributorsurl:c28d60b998176c0eweakconsumedcited only
2024Diphenhydramine legal status by jurisdiction (Erowid/Wikipedia/ACS sources combined)Variousurl:b060ec4995f7a05bweakconsumedcited only
2024Diphenhydramine Overdose: A Case Report and Topic Review of Prehospital Diagnosis and Treatment.Frank MA, Lund J, Langley DM, Annis M, Peredy TR · Cureusdoi:10.7759/cureus.70719weakconsumed2 sections
2023A TikTok 'Benadryl Challenge' death - A case report and review of the literature.Elkhazeen A, Poulos C, Zhang X, Cavanaugh J, Cain M · Journal of Forensic Sciencesdoi:10.1111/1556-4029.15149weakconsumed2 sections
2023Diphenhydramine - StatPearls (NBK526010)Sicari V, Zabbo CP · StatPearls Publishingurl:5897be19afc8eb58weakconsumedcited only
2023Diphenhydramine Toxicity - StatPearls (NBK557578)Reiter PD, Bhatt M · StatPearls Publishingurl:de86627bfcc84cd5weakconsumedcited only
2022Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.O'Donnell KC, Mennenga SE, Owens LT, et al. · Contemporary Clinical Trialsdoi:10.1016/j.cct.2022.106976moderateconsumed1 section
2021LD50 data for diphenhydramine hydrochloride (MSDS/safety data)Various (MSDS sources)url:bc4c41cd5fbd55d0weakconsumedcited only
2020Adverse events associated with diphenhydramine in children, 2008-2015.Palmer RB, Reynolds KM, Banner W, Bond GR, Kauffman RE, Paul IM, Green JL, Dart RC · Clinical Toxicologydoi:10.1080/15563650.2019.1609683moderateconsumed3 sections
2019A Comparison of Resource Utilization in the Management of Anticholinergic Delirium Between Physostigmine and Nonantidote Therapy.Boley SP, Stellpflug SJ · The Annals of Pharmacotherapydoi:10.1177/1060028019846654moderateconsumed1 section
2019IV Lipid Emulsion Infusion in the Treatment of Severe Diphenhydramine Overdose.Cherukuri SV, Purvis AW, Tosto ST, Velayati A · The American Journal of Case Reportsdoi:10.12659/ajcr.912523weakconsumedcited only
2018A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research.Sanger GJ, Andrews PLR · Frontiers in Pharmacologydoi:10.3389/fphar.2018.00913strongconsumed2 sections
2018Extracorporeal Cardiopulmonary Resuscitation After Diphenhydramine Ingestion.Labarinas S, Meulmester K, Greene S, Thomas J, Virk M, Erkonen G · Journal of Medical Toxicologydoi:10.1007/s13181-018-0672-6weakconsumed1 section
2017Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL · Journal of Clinical Sleep Medicinedoi:10.5664/jcsm.6470strongconsumed2 sections
2016A Literature Review of the Use of Sodium Bicarbonate for the Treatment of QRS Widening.Bruccoleri RE, Burns MM · Journal of Medical Toxicologydoi:10.1007/s13181-015-0483-ystrongconsumed3 sections
2015International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, et al. · Pharmacological Reviewsdoi:10.1124/pr.114.010249strongconsumed5 sections
2015Open channel block of NMDA receptors by diphenhydramine.Föhr KJ, Zeller K, Georgieff M, Köster S, Adolph O · Neuropharmacologydoi:10.1016/j.neuropharm.2015.08.021moderateconsumed3 sections
2015The Use of Physostigmine by Toxicologists in Anticholinergic Toxicity.Watkins JW, Schwarz ES, Arroyo-Plasencia AM, Mullins ME · Journal of Medical Toxicologydoi:10.1007/s13181-014-0452-xmoderateconsumed1 section
2013[Diphenhydramine addiction and detoxification. A systematic review and case report].Erbe S, Bschor T · Psychiatrische Praxisdoi:10.1055/s-0032-1332949strongconsumed2 sections
2013Toxicological identification of diphenhydramine (DPH) in suicide.Eckes L, Tsokos M, Herre S, Gapert R, Hartwig S · Forensic Science, Medicine, and Pathologydoi:10.1007/s12024-012-9383-5moderateconsumed1 section
2006Antimuscarinic actions of antihistamines on the heart.Liu H, Zheng Q, Farley JM · Journal of Biomedical Sciencepmid:16453179moderateconsumed3 sections
2006Sedation and memory: studies with a histamine H-1 receptor antagonist.Turner C, Handford AD, Nicholson AN · Journal of Psychopharmacologypmid:16401664moderateconsumed4 sections
2003Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly subjects.Glass JR, Sproule BA, Herrmann N, Streiner D, Busto UE · Journal of Clinical Psychopharmacologypmid:12826988moderateconsumed2 sections
Show all 41 sources — 11 more
Sources 31 to 41
yearsourcetierstatusfeeds
2003Classic histamine H1 receptor antagonists: a critical review of their metabolic and pharmacokinetic fate from a bird's eye view.Sharma A, Hamelin BA · Current Drug Metabolismpmid:12678691strongconsumed4 sections
2003Pharmacokinetics of diphenhydramine in healthy volunteers with a dimenhydrinate 25 mg chewing gum formulation.Valoti M, Frosini M, Dragoni S, Fusi F, Sgaragli G · Methods and Findings in Experimental and Clinical Pharmacologypmid:12851661moderateconsumed1 section
1998Diphenhydramine toxicity: comparisons of postmortem findings in diphenhydramine-, cocaine-, and heroin-related deaths.Karch SB · The American Journal of Forensic Medicine and Pathologypmid:9662109weakconsumed1 section
1997Lack of sedative and cognitive effects of diphenhydramine and cyclobenzaprine in elderly volunteers.Lines C, Traub M, Raskin S, Mant T, Reines S · Journal of Psychopharmacologypmid:9443520moderateconsumed1 section
1995[An anticholinergic syndrome with hallucinatory psychosis after diphenhydramine poisoning].Lang K, Sigusch H, Müller S · Deutsche Medizinische Wochenschriftpmid:7497894weakconsumed2 sections
1991Trifluoperazine inhibits phosphoinositide hydrolysis as a histamine H1-receptor antagonist.Nakahata N, Ishimoto H, Takahashi A, Ohmori K, Kurita M · European Journal of Pharmacologypmid:1685127moderateconsumed2 sections
1990Diphenhydramine kinetics following intravenous, oral, and sublingual dimenhydrinate administration.Scavone JM, Luna BG, Harmatz JS, von Moltke L, Greenblatt DJ · Biopharmaceutics & Drug Dispositionpmid:2328304moderateconsumed1 section
1986[Pharmacokinetics and bioavailability of diphenhydramine in man].Gielsdorf W, Pabst G, Lutz D, Graf F · Arzneimittel-Forschungpmid:3718600moderateconsumed1 section
1986H1-histamine receptors on human astrocytoma cells.Nakahata N, Martin MW, Hughes AR, Hepler JR, Harden TK · Molecular Pharmacologypmid:2419744moderateconsumed1 section
1985Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines).Paton DM, Webster DR · Clinical Pharmacokineticspmid:2866055strongconsumed2 sections
1978Effects of terfenadine and diphenhydramine alone or in combination with diazepam or alcohol on psychomotor performance and subjective feelings.Moser L, Hüther KJ, Koch-Weser J, Lundt PV · European Journal of Clinical Pharmacologypmid:33053moderateconsumed2 sections

4Docket

one filing per activity — decisions, correspondence, reports

  1. 0012026-04-24revisionRevision 1

    Initial LLM generation (v5 pipeline, wiki)

    psx:substance/diphenhydramine/version/1
  2. 0022026-06-04proposal32 value proposals approved together

    one review action inferred from a shared reviewer and instant — the graph records one activity per proposal

    32 items in this filing

    • dose_tier · light
    • dose_tier · common
    • dose_tier · strong
    • dose_tier · heavy
    • timeline · oral · onset
    • timeline · oral · come_up
    • timeline · oral · peak
    • timeline · oral · plateau
    • timeline · oral · resolution
    • timeline · oral · afterglow
    • toxicity
    • dependence · full
    • withdrawal
    • tolerance
    • dosage · oral
    • duration · oral · onset
    • duration · oral · come_up
    • duration · oral · peak
    • duration · oral · offset
    • duration · oral · total
    • duration · oral · aftereffects
    • contraindication · age
    • contraindication · pregnancy_breastfeeding
    • contraindication · other
    • contraindication · other
    • contraindication · hepatic
    • contraindication · age
    • contraindication · age
    • contraindication · neurological
    • contraindication · cardiovascular
    • contraindication · respiratory
    psx:substance/diphenhydramine/proposal/dose_tier/365f312d-d07b-4880-8c90-d4d66daaa03f
  3. 0032026-06-04publicationPublication — backfill
  4. 0042026-09-27revisionr1.a1

    brief-overview retired 2026-09-30 (founder): Description reads the essential summary for every substance.

    psx:substance/diphenhydramine/version/2

5Issued documents

what the notice, info card and emergency page said, by hash

Issued documents
documentcontent hashissuedfrom versionsuperseded
emergency202c57e4fe575e44059df0ab…2026-10-19 20:31Revision 1current
info_cardeb1efe8b4354f15f8d577408…2026-10-19 20:31Revision 1current
emergencye2acd002694f8aad19cda75f…2026-09-04 04:29Revision 1superseded2026-10-19
info_card348705653ea53dc6ece037d0…2026-09-04 04:29Revision 1superseded2026-10-19
notice034a58fba8b8cf2dbf968fb5…2026-09-04 04:29Revision 1current